These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28271901)

  • 1. Nanocrystal Dissolution Kinetics and Solubility Increase Prediction from Molecular Dynamics: The Case of α-, β-, and γ-Glycine.
    Parks C; Koswara A; Tung HH; Nere NK; Bordawekar S; Nagy ZK; Ramkrishna D
    Mol Pharm; 2017 Apr; 14(4):1023-1032. PubMed ID: 28271901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubility curves and nucleation rates from molecular dynamics for polymorph prediction - moving beyond lattice energy minimization.
    Parks C; Koswara A; DeVilbiss F; Tung HH; Nere NK; Bordawekar S; Nagy ZK; Ramkrishna D
    Phys Chem Chem Phys; 2017 Feb; 19(7):5285-5295. PubMed ID: 28149994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turbidimetric measurement and prediction of dissolution rates of poorly soluble drug nanocrystals.
    Crisp MT; Tucker CJ; Rogers TL; Williams RO; Johnston KP
    J Control Release; 2007 Feb; 117(3):351-9. PubMed ID: 17239469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q₁₀ as naked nanocrystals.
    Sun J; Wang F; Sui Y; She Z; Zhai W; Wang C; Deng Y
    Int J Nanomedicine; 2012; 7():5733-44. PubMed ID: 23166438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation.
    Jiang T; Han N; Zhao B; Xie Y; Wang S
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1230-9. PubMed ID: 22229827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method.
    Shi-Ying J; Jin H; Shi-Xiao J; Qing-Yuan L; Jin-Xia B; Chen HG; Rui-Sheng L; Wei W; Hai-Long Y
    Chin J Nat Med; 2014 Jan; 12(1):71-80. PubMed ID: 24484600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced oral bioavailability of glycyrrhetinic acid via nanocrystal formulation.
    Lei Y; Kong Y; Sui H; Feng J; Zhu R; Wang W
    Drug Deliv Transl Res; 2016 Oct; 6(5):519-25. PubMed ID: 27206446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanosizing techniques for improving bioavailability of drugs.
    Al-Kassas R; Bansal M; Shaw J
    J Control Release; 2017 Aug; 260():202-212. PubMed ID: 28603030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissolution study of nanocrystal powders of a poorly soluble drug by UV imaging and channel flow methods.
    Sarnes A; Østergaard J; Jensen SS; Aaltonen J; Rantanen J; Hirvonen J; Peltonen L
    Eur J Pharm Sci; 2013 Nov; 50(3-4):511-9. PubMed ID: 23999036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring bulk volume, particle size and particle motion definitions to increase the predictive ability of in vitro dissolution simulations.
    Navas-Bachiller M; Persoons T; D'Arcy DM
    Eur J Pharm Sci; 2022 Jul; 174():106185. PubMed ID: 35398291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolution and coarsening of polydisperse, polymorph drug particles liberated from a disintegrating finished dosage form: Theoretical considerations.
    Horkovics-Kovats S
    Eur J Pharm Sci; 2016 Aug; 91():265-77. PubMed ID: 27155254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ determination of the saturation solubility of nanocrystals of poorly soluble drugs for dermal application.
    Colombo M; Staufenbiel S; Rühl E; Bodmeier R
    Int J Pharm; 2017 Apr; 521(1-2):156-166. PubMed ID: 28223247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into pharmaceutical nanocrystal dissolution: a molecular dynamics simulation study on aspirin.
    Greiner M; Elts E; Briesen H
    Mol Pharm; 2014 Sep; 11(9):3009-16. PubMed ID: 25090160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissolution enhancement and in vitro performance of clarithromycin nanocrystals produced by precipitation-lyophilization-homogenization method.
    Morakul B; Suksiriworapong J; Chomnawang MT; Langguth P; Junyaprasert VB
    Eur J Pharm Biopharm; 2014 Nov; 88(3):886-96. PubMed ID: 25201298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an oral rutin nanocrystal formulation.
    Mauludin R; Müller RH; Keck CM
    Int J Pharm; 2009 Mar; 370(1-2):202-9. PubMed ID: 19114097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronotherapeutically Modulated Pulsatile System of Valsartan Nanocrystals-an In Vitro and In Vivo Evaluation.
    Biswas N; Kuotsu K
    AAPS PharmSciTech; 2017 Feb; 18(2):349-357. PubMed ID: 26961969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat.
    Tu L; Yi Y; Wu W; Hu F; Hu K; Feng J
    Int J Pharm; 2013 Dec; 458(1):135-40. PubMed ID: 24120729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
    Ige PP; Baria RK; Gattani SG
    Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical and pharmacokinetic characteristics of different types of fenofibrate nanocrystals prepared by different bottom-up approaches.
    Zhang H; Meng Y; Wang X; Dai W; Wang X; Zhang Q
    Drug Deliv; 2014 Dec; 21(8):588-94. PubMed ID: 24320001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.